Hong Kong Report: Joint Universities & Government evaluation

   Effectiveness of antimicrobial curtains on reducing bacterial contamination

To download a copy of this report, click or tap here.

Summary:

An independent study carried out jointly by hospitals and government health departments in Hong Kong evaluated the antimicrobial efficacy and cost benefits of two types of disposable curtain compared with traditional fabric curtains – one with built-in silver additives alongside Endurocide® Antimicrobial & Sporicidal Curtains.

This study, published in the Journal of Infection Control & Hospital Epidemiology, included twice-weekly and weekly culture samples collected from 12 rooms and 10 cubicles across 10 hospitals over 12 months, totalling in over 3000 samples. It evaluated both bioburden and hanging times of all three types – and the results came out strongly in favour of the Endurocide®Curtains.

   

Its findings included:

  • Compared with standard curtains, Endurocide® Curtains were “highly effective in reducing the bioburden” and “percentages of MDRO [multidrug-resistant organisms] contamination were also significantly lower” (98-100% reductions) – “even after prolonged use.”
  • Silver-additive curtains had higher levels of bioburden and MDRO contamination than Endurocide® Curtains with the differences stated as being “significant.”
  • Standard curtains became contaminated “within 5 days” - Endurocide® Curtains took 27.6 times longer at 138 days; silver curtains were contaminated after only 4 days.
  • Silver-additive curtains have “moderate antibacterial activity for up to 3 months” but “fail to demonstrate antibacterial efficacy after extended use.”

   

The report concluded:

  • Curtains that resist MDRO contamination for >19 weeks […] could potentially improve patient safety by eliminating a source of healthcare-associated pathogens.”
  • Endurocide® Curtains “did effectively reduce the microbial burden and MDRO contamination compared with the standard curtain, even after extended use in an active clinical setting” - “but not antimicrobial curtain A (built-in silver)”.
  • Using Endurocide® Curtains in place of standard curtains “could avert the costs related to curtain changing, laundering, and revenue loss, in addition to improving patient care by removing an environmental source of MDROs.”

To download a copy of this report, click or tap here.


For further information on our trials, please contact us.


* DISCLAIMER: While Endurocide®  Antimicrobial & Sporicidal Curtains have been independently tested to remain antimicrobially and sporicidally effective for up to two years in-situ, the actual length of curtain use achieved will depend on a variety of factors, including, but not limited to; individual hospital practices, the natural longevity of polypropylene and the risk of the curtain being soiled from items such as blood, urine and general spills etc.  Curtains should always be replaced when visibly soiled. Any timescales provided/referenced are always offered as a guideline only and under no circumstances whatsoever constitute a guarantee.